Diagnóstico y seguimiento de 12 casos de peritonitis esclerosante asociada a diálisis peritoneal crónica en Chile: Experience in 12 patients on peritoneal dialysis / Encapsulating peritoneal sclerosis
Rev. méd. Chile
; 145(1): 41-48, ene. 2017. ilus, graf, tab
Article
em Es
| LILACS
| ID: biblio-845502
Biblioteca responsável:
CL1.1
ABSTRACT
Background:
Encapsulating peritoneal sclerosis (EPS) is a complication of peritoneal dialysis (PD) with a low prevalence but high mortality. It is characterized by peritoneal inflammation and fibrosis with subsequent development of intestinal encapsulation. It is associated with a long lapse on PD, frequent episodes of peritonitis, high glucose solution use, and high peritoneal transport status.Aim:
To report the clinical features of patients on PD, who developed EPS. Material andMethods:
Review of medical records of 12 patients aged 43 ± 10 years (eight women) who developed EPS.Results:
The mean time spent on PD was 98 months. The main clinical manifestations were abdominal pain in 82% and ultrafiltration failure in 63%. In 92%, there was a history of peritonitis and 75% had high peritoneal transport at the time of diagnosis. The main findings in computed tomography were peritoneal calcification and thickening. There was a biopsy compatible with the diagnosis in 10 cases. Treatment consisted in withdrawal from PD, removal of PD catheter and the use of corticoids and tamoxifen. After withdrawal from PD 50% of patients became asymptomatic. The rest had intermittent abdominal pain and altered bowel movements. Two patients died (17%).Conclusions:
EPS is a serious complication of PD, which should be suspected in any patient with compatible clinical symptoms, long time on PD, multiple episodes of peritonitis and high peritoneal transport profile.Palavras-chave
Texto completo:
1
Base de dados:
LILACS
Assunto principal:
Peritonite
/
Diálise Peritoneal
/
Fibrose Peritoneal
Idioma:
Es
Ano de publicação:
2017
Tipo de documento:
Article